Enhancing Immune Tolerance and Insulin Secretion of Mesenchymal Stem Cell-Derived Insulin-Producing cells via Interferon-γ and Tumor Necrosis Factor-α Priming
Reports of Biochemistry and Molecular Biology · 2025
DOI: 10.66224/rbmb.14.2.155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reports of Biochemistry and Molecular Biology, 2025. Verfasst von Mohga Mohamed Al-Issawi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Department, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Mesenchymal stem cells (MSCs) have the potential to treat type 1 diabetes mellitus (T1DM) by differentiating into insulin-producing cells (IPCs). However, various immunological factors were limiting the therapeutic efficacy of transplanted MSC-derived IPCs. Preconditioning MSCs with proinflammatory cytokines was proven to enhance their immunosuppressive capabilities. Yet, it remains unclear how cytokine stimulation influences the immunoregulatory features of theses differentiated IPCs. Therefore, we aimed to investigate the potential role of tumor necrosis factor-alpha (TNF-α) and/or interferon-gamma (IFN-γ)–primed MSC-derived IPCs in inducing and regulating immunological tolerance.
Methods
MSCs were isolated from human adipose tissue ( hAT-MSCs) and differentiated into IPCs. Subsequently, the cells were assigned into five groups as follows: the control (hAT-MSCs) group, the differentiated (IPCs) group, the differentiated cells primed with IFN-γ (IPCs+ IFN-γ group), the differentiated cells primed with TNF-α (IPCs+ TNF-α group), the differentiated cells primed with both cytokines (IPCs+ Mix group). Flow cytometry, reverse transcription polymerase chain reaction (RT-PCR), and enzyme-linked immunosorbent assay (ELISA) were employed to detect the expression of immunomodulators, insulin/c-peptide, and pancreatic gene expression.
Results
The results indicated that IPCs treated with both cytokines exhibited the highest expression of insulin/c-peptide and pancreatic genes, as well as the immune checkpoints programmed death ligand 1 (PD-L1) and kynurenine (KYN), which are immunosuppressants. Furthermore, IFN-γ priming also enhanced the expression of the immunological regulators: human leukocyte antigen class 1 (HLA-ABC) and class 2 (HLA-DR).
Conclusions
Preconditioning IPCs with IFN-γ/TNF-α enhances their immunomodulatory profile through checkpoint molecules and insulin secretion, suggesting a novel immunological strategy for treating T1DM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biotechnology Department, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
- Pathology Department, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
- Chemistry Department, Division of Biochemistry, Faculty of Sciences, Mansoura University, Mansoura, Egypt.
Zitieren
APA
Al-Issawi, M. M., Gabr, M. M., Khater, S. M., & Abdel-Aziz, A. F. (2025). Enhancing Immune Tolerance and Insulin Secretion of Mesenchymal Stem Cell-Derived Insulin-Producing cells via Interferon-γ and Tumor Necrosis Factor-α Priming. Reports of Biochemistry and Molecular Biology. https://doi.org/10.66224/rbmb.14.2.155
Vancouver
Al-Issawi MM, Gabr MM, Khater SM, Abdel-Aziz AF. Enhancing Immune Tolerance and Insulin Secretion of Mesenchymal Stem Cell-Derived Insulin-Producing cells via Interferon-γ and Tumor Necrosis Factor-α Priming. Reports of Biochemistry and Molecular Biology. 2025. doi:10.66224/rbmb.14.2.155
BibTeX
@article{AlIssawi2025,
author = {Al-Issawi, Mohga Mohamed and Gabr, Mahmoud Mohamed and Khater, Sherry Mohamed and Abdel-Aziz, Abdel-Aziz Fatouh},
title = {Enhancing Immune Tolerance and Insulin Secretion of Mesenchymal Stem Cell-Derived Insulin-Producing cells via Interferon-γ and Tumor Necrosis Factor-α Priming},
journal = {Reports of Biochemistry and Molecular Biology},
year = {2025},
doi = {10.66224/rbmb.14.2.155}
}
EUVIMED